Zomedica Pharmaceuticals Corp (NY: ZOM )
0.1365
+0.0014
(+1.04%)
Official Closing Price
Updated: 8:00 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Zomedica Pharmaceuticals Corp
![](https://investorplace.com/wp-content/uploads/2021/04/zom-stock-1.jpg)
![](https://investorplace.com/wp-content/uploads/2021/04/zom-stock-1.jpg)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/29220.png?v=1)
From Zomedica Corp.
Via AccessWire
![](https://investorplace.com/wp-content/uploads/2021/04/zom-stock-1.jpg)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/29220.png?v=1)
Zomedica Announces Fourth Quarter and 2021 Revenues of $4.1 Million; 73.9% Gross Margin
February 25, 2022
From Zomedica Corp.
Via AccessWire
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/earnings_image_2075.jpeg)
![](https://investorplace.com/wp-content/uploads/2020/06/calendar1600.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/premkt_movers_557.png)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/29220.png?v=1)
Zomedica Appoints Adrian Lock to Lead Sales Organization
February 15, 2022
From Zomedica Corp.
Via AccessWire
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_394.png)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/29220.png?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/29220.png?v=1)
![](https://investorplace.com/wp-content/uploads/2021/04/zom-stock-1.jpg)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/29220.png?v=1)
![](https://investorplace.com/wp-content/uploads/2020/04/stockstobuy1600_12.jpg)
![](https://investorplace.com/wp-content/uploads/2021/04/zom-stock-1.jpg)
![](https://investorplace.com/wp-content/uploads/2021/01/veterinarian-zom-1600.jpg)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/jon-tyson-j2jlmdrgose-unsplash.jpg?width=720)
![](https://investorplace.com/wp-content/uploads/2021/12/meme-stocks-1024x576.png)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/29220.png?v=1)
Zomedica to Present at H.C. Wainwright BioConnect 2022 Conference
December 15, 2021
From Zomedica Corp.
Via AccessWire
![](https://investorplace.com/wp-content/uploads/2019/08/stocks-to-avoid.jpg)
![](https://investorplace.com/wp-content/uploads/2021/03/penny-stocks.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/premkt_movers_507.png)
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600gene.jpg)
![](https://investorplace.com/wp-content/uploads/2021/04/zom-stock-1.jpg)
![](https://investorplace.com/wp-content/uploads/2021/04/zom-stock-1.jpg)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/29220.png?v=1)
Zomedica Announces Third Quarter 2021 Financial Results
November 12, 2021
From Zomedica Corp.
Via AccessWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.